Accendra Health ACH

Accendra Health receives NYSE compliance notice

Form
8-K
Filed
Importance
Routine
  1. Received NYSE notice on Oct 6, 2026 for stock price below $1.00
  2. Has 6 months to regain compliance with NYSE standards
  3. May consider reverse stock split with shareholder approval
  4. Stock remains listed on NYSE during cure period

Written from the 8-K on EDGAR. Check the filing before you rely on it.

Get an email when Accendra Health files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 5047 and related industry codes: the same peer list as the financial tables.